[1] Beers M and Berkow R.  The Merck Manual 17^th Ed.  1997.  Pp: 469-473.

[2] Pizzorno J, Murray M, and Joiner-Bey H.  The Clinician's Handbook of Natural Medicine. Churchill Livingstone New York. 1999. Pp: 372-377.

[3] Pizzorno J, Murray M, and Joiner-Bey H.  The Clinician's Handbook of Natural Medicine. Churchill Livingstone New York. 1999. Pp: 372-377.

[4] www.osteo.org National Institute of Health Osteoporosis and Related Bone Diseases Natural Resource Center. Oct 2004

[5] www.osteo.org National Institute of Health Osteoporosis and Related Bone Diseases Natural Resource Center. Oct 2004

[6] Beers M and Berkow R.  The Merck Manual 17^th Ed.  1997.  Pp: 469-473.

[7] Beers M and Berkow R.  The Merck Manual 17^th Ed.  1997.  Pp: 469-473.

[8] Agnusdei D et al.  A double blind placebo controlled trial of ipriflavone for prevention of postmenopausal spinal bone loss.  Calcif Tissue Int.  1997 Aug; 61(2): 142-7.

[9] Ohta H et al.  Effects of one year ipriflavone treatment on lumbar bone mineral density and bone metabolic markers in postmenopausal women with low bone mass.  Horm Res.  1999; 51(4): 178-83.

[10] Scheiber MD and Rebar RW.  Isoflavones and postmenopausal bone health: a viable alternative to estrogen therapy?  Menopause 1999 Fall; 6(3): 233-241.

[11] Ruml LA, Sakhee K, Peterson R, Adams-Huet B, Pak CY.  The effect of calcium citrate on bone mineral density in early and mid-menopause period: a randomized placebo controlled study.  Am J Ther.  1999 Nov 6; (6): 303-311.

[12] Riggs BL et al.  Long term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women.  Bone Miner Res.  1998 Feb; 13(2): 168-174.

[13] Chen JT et al.  1-alpha-hydroxyvitamin D3 treatment reduces bone turnover and modulates calcium-regulating hormones in early postmenopausal women.  Bone 1997 June; 20(6): 557-562.

[14] Sairamen S et al.  Bone mass and markers of bone and calcium metabolism in postmenopausal women treated with 1,25 dihydroxyvitamin D (calcitrol) for four years.  Calcif Tissue Int. 2000 Aug; 67(2): 122-127.

[15] Braam LA et al.  Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age.  Calcif Tissue Int.  2003 Jul; 73(1): 21-26.

[16] Gur A, Colpan L, Nas K, Cevik R, Sarac J, Erdogan F, Duz MZ.  The role of trace minerals in the pathogenesis of postmenopausal osteoporosis and a new effect of calcitonin.  J Bone Miner Metab.  2002; 20(1): 39-43.

[17] Schaafsma A, de Vries PJ, Saris WH.  Delay of natural bone loss by higher intakes of specific minerals and vitamins.  Crit Rev Food Sci Nutr.  2001 May; 41(4): 225-249.

[18] Saltman PD, Strause LG.  The role of trace minerals in osteoporosis.  J Am Coll Nutr.  1993 Aug; 12(4): 384-389.

[19] Schaafsma A, de Vries PJ, Saris WH.  Delay of natural bone loss by higher intakes of specific minerals and vitamins.  Crit Rev Food Sci Nutr.  2001 May; 41(4): 225-249.